Latest News

  • Alkermes Presents New Clinical Data on ALKS 4230 in Mini Oral Presentation at 2020 European Society for Medical Oncology (ESMO) Virtual Congress Read More
  • Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual Experience Read More
  • Alkermes to Take Part in Cantor Virtual Global Healthcare Conference Read More
  • Alkermes to Present New Data on Investigational Immuno-Oncology Candidate, ALKS 4230, at the 2020 European Society for Medical Oncology (ESMO) Virtual Congress Read More

Investors

Response to Current Events